Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2619-2626
Published online before print September 27, 2007, doi: 10.1161/ATVBAHA.107.150482
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/12/2619    most recent
ATVBAHA.107.150482v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findley, C. M.
Right arrow Articles by Kontos, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Findley, C. M.
Right arrow Articles by Kontos, C. D.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2619.)
© 2007 American Heart Association, Inc.


Vascular Biology

VEGF Induces Tie2 Shedding via a Phosphoinositide 3-Kinase/Akt–Dependent Pathway to Modulate Tie2 Signaling

Clarence M. Findley; Melissa J. Cudmore; Asif Ahmed; Christopher D. Kontos

From the Department of Pharmacology and Cancer Biology (C.M.F., C.D.K.), Duke University Medical Center and the Duke University School of Medicine (C.M.F.), Durham, NC; the Department of Medicine (C.M.F., C.D.K.), Division of Cardiovascular Medicine, Duke University Medical Center, Durham, NC; and the Department of Reproductive and Vascular Biology (M.J.C., A.A.), Institute for Biomedical Research, The Medical School, University of Birmingham, UK.

Correspondence to Christopher D. Kontos, Box 3629 DUMC, Durham, NC 27710. E-mail cdkontos{at}duke.edu

Objective— Tie2 and its ligands, the angiopoietins (Ang), are required for embryonic and postnatal angiogenesis. Previous studies have demonstrated that Tie2 is proteolytically cleaved, resulting in the production of a 75-kDa soluble receptor fragment (sTie2). We investigated mechanisms responsible for Tie2 shedding and its effects on Tie2 signaling and endothelial cellular responses.

Methods and Results— sTie2 bound both Ang1 and Ang2 and inhibited angiopoietin-mediated Tie2 phosphorylation and antiapoptosis. In human umbilical vein endothelial cells, Tie2 shedding was both constitutive and induced by treatment with PMA or vascular endothelial growth factor (VEGF). Constitutive and VEGF-inducible Tie2 shedding were mediated by PI3K/Akt and p38 MAPK. Tie2 shedding was blocked by pharmacological inhibitors of either PI3K or Akt as well as by overexpression of the lipid phosphatase PTEN. In contrast, sTie2 shedding was enhanced by overexpression of either dominant negative PTEN, which increased Akt phosphorylation, or constitutively active, myristoylated Akt.

Conclusions— These findings demonstrate that VEGF regulates angiopoietin-Tie2 signaling by inducing proteolytic cleavage and shedding of Tie2 via a novel PI3K/Akt-dependent pathway. These results suggest a previously unrecognized mechanism by which VEGF may inhibit vascular stabilization to promote angiogenesis and vascular remodeling.

Tie2 plays an important role in vascular remodeling. We demonstrate that soluble Tie2 shedding is induced by vascular endothelial growth factor (VEGF) in a phosphoinositide 3-kinase/Akt-dependent manner. These findings suggest a novel mechanism by which VEGF may inhibit Tie2-mediated vascular stabilization to promote angiogenesis and vascular remodeling.


Key Words: Tie2 • VEGF • phosphoinositide 3-kinase • Akt • endothelium




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. M. Findley, R. G. Mitchell, B. D. Duscha, B. H. Annex, and C. D. Kontos
Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. P. Cooke
Critical Determinants of Limb Ischemia
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 394 - 396.
[Full Text] [PDF]